Summit Speakers and Panelists

 
As VP of Science, John Wilbanks runs the Science Commons project at Creative Commons. He came to Creative Commons from a Fellowship at the World Wide Web Consortium in Semantic Web for Life Sciences. Previously, he founded and led to acquisition Incellico, a bioinformatics company that built semantic graph networks for use in pharmaceutical research & development. Previously, John was the first Assistant Director at the Berkman Center for Internet and Society at Harvard Law School and also worked in US politics as a legislative aide to U.S. Representative Fortney (Pete) Stark.

John holds a Bachelor of Arts in Philosophy from Tulane University and studied modern letters at the Universite de Paris IV (La Sorbonne). He is a research affiliate at the MIT Computer Science and Artificial Intelligence Laboratory in the project on Mathematics and Computation. John also serves on the Advisory Boards of the U.S. National Library of Medicine’s PubMed Central, the Open Knowledge Foundation, the Open Knowledge Definition, and the International Advisory Board of the Prix Ars Electronica’s Digital Communities awards. He also serves on the Board of Directors of the Fedora Commons digital repository organization. 


Ana M. Viamonte Ros M.D., MPH, was named Secretary of the Florida Department of Health and Florida’s first Surgeon General by Governor Charlie Crist in January 2007.  She is the first woman and the first Cuban American to hold this position.

Secretary Viamonte Ros is dedicated to advancing the Department of Health’s vision of ensuring all Floridians are healthy, safe and well.  She is committed to advocating for better healthcare in Florida, making the healthcare system more user-friendly, promoting healthy habits among Florida’s youth, preparing the state for any type of disaster, reducing health disparities and leading Floridians to better health by example.
   
In 1960, her family fled Cuba.  Having come from a family of refugees, she understands the struggles of Floridians and is passionate about ensuring public health programs help Floridians achieve a higher quality of life.
  
Secretary Viamonte Ros earned her medical degree in 1983 from the University of Miami School of Medicine, graduating with several awards and honors.  She attended residency training in radiology at Mount Sinai Medical Center in Miami Beach, Florida and the Armed Forces Institute of Pathology in Washington, D.C.
  
In 2005, Secretary Viamonte Ros received her Master of Public Health degree (MPH), with a concentration on family and community health, from the Harvard School of Public Health.  There, she was also the recipient of the Gareth Green Award for Excellence in Public Health, the highest student award.
  
She came to DOH from Armor Correctional Health Services, where she worked to organize and monitor the health care delivery services in Florida’s correctional institutions, and also oversaw the development of medical discharge programs.  In her role, Secretary Viamonte Ros traveled with a team of medical professionals to the Dominican Republic to help prevent the spread of HIV among inmates by conducting rapid HIV testing and offering support.
  
Secretary Viamonte Ros remains committed to advancing healthcare delivery systems in public health settings and has volunteered with programs like the Camillus House Homeless Initiative in Miami, the Health through Walls International Health Outreach, and the Brookside Community Health Center in Jamaica Plain, Massachusetts.  Throughout all her community volunteer projects, she has been a strong advocate for disadvantaged individuals and minority communities.
    
She has written several articles in the areas of mental health, radiology and family health, in addition to lecturing at numerous health care symposia.

Secretary Viamonte Ros is the mother of two grown children.
     


 
C. Russell Allen
President

Russell Allen joined BioFlorida in August 2006 and leads the organization to meet the demands of Florida’s growing bioscience industry.

Prior to BioFlorida, Russell was President and CEO of BioSouth, Inc., a nonprofit organization for the southern U.S. bioscience industry, dedicated to support of commercialization, licensing and partnering efforts across the region. Russell organized the annual conferences, BioFusion and the CDC Technology Forum, and instituted member programs to help facilitate global partnerships for southern life science companies and institutions.
Russell began his professional career selling and marketing laboratory research equipment and supplies to the bioscience industry in the San Francisco Bay area. He moved from biotechnology sales to the high-tech marketing sector in Atlanta, and in 1996 co-founded Newton Park, Inc., one of the region’s most successful and respected new media agencies. As CEO, Allen led the organization from start-up to one of the fastest growing companies and top five agencies in Atlanta.
In 2001, Russell founded iQuotient and its subsidiary bioscience business consulting and marketing firm, BioQuotient. BioQuotient activities took Russell to his position as Vice President of Bioscience Industry Development at the Metro Atlanta Chamber of Commerce where he led the strategy to support and grow the Georgia bioscience industry.
Mr. Allen received a bachelor’s degree in biology from Pepperdine University and a certificate in Biotech Enterprise Management from the Owen Graduate School of Business at Vanderbilt University.
  

    
Sanford L. Meeks, PhD, serves as Associate Professor and Chief of Physics at M.D. Anderson Cancer Center Orlando, and has an adjunct faculty appointment in the Department of Neurological Surgery at the University of Florida.  Additionally, he currently serves as the Vice Chairman for the Institutional Review Board at M.D. Anderson-Orlando, and is President of the Florida Chapter of the American Association of Physicists in Medicine.
   
Dr. Meeks earned his BS in physics from Florida Southern College, his M.S. in Physics from Florida State University, his PhD in Medical Physics from the University of Florida in 1994, and certification in Therapeutic Radiologic Physics from the American Board of Radiology in 1997. He joined the faculty at the University of Florida in 1995 and held appointments in the Departments of Neurological Surgery, Radiation Oncology, and Nuclear and Radiological Engineering. In 1999, he joined the Department of Radiation Oncology at the University of Iowa as Associate Professor and Director of Medical Physics, and he held a secondary appointment in the Department of Biomedical Engineering. Dr. Meeks has co-authored more than 80 peer-reviewed manuscripts, and 15 book chapters. His primary research interest is image-guided radiation therapy, which has been supported by more than $3.5M in grants and research contracts from State and Federal Agencies, private foundations, and industry.
  

  
Dr. Shahla Masood is a Persian born physician, who currently holds the positions of Professor and Chair of the Department of Pathology at University of Florida College of Medicine – Jacksonville and Chief of Pathology and Laboratory Medicine at Shands Jacksonville. She is also the Director of the Pathology Residency training, as well as Cytopathology and Breast Pathology Fellowship programs. An internationally recognized expert in breast cancer diagnosis and prognosis, Dr. Masood has fostered the concept of an integrated multidisciplinary approach in breast cancer care, research, and education. She is the founder and Editor-in-Chief of The Breast Journal, the founder and the Past President of the “International Society of Breast Pathology”, and the Director of the “Annual Multidisciplinary Symposium on Breast Disease” and “The Breast Cancer Public Forum.” Dr. Masood is heavily involved in the study of minimally invasive procedures such as fine needle aspiration biopsy and ductal lavage in providing diagnostic and prognostic information in high risk and breast cancer risk patients. She has defined the cytomorphology of high-risk proliferative breast disease in early 1990’s and has pioneered the concept of cytomorphology as a breast cancer predictor. Dr. Masood is the author of the textbooks; “Cytopathology of the Breast”, “Contemporary Issues in Breast Cytopathology”, and numerous publications. She is a frequent speaker at national and international symposiums and is a member of several consensus meetings. She is also a member of board of trustees of “National Consortium of Breast Centers” and the Steering Committee of the “Breast Health Global Initiative” and a member of the “National Accreditation Program for Breast Centers”. Dr. Masood is a patient advocate, a partner in community affairs, and an accomplished artist and gourmet cook. She has received numerous awards and recognition. To name a few, Dr. Masood is the recipient of the 2005  Super Bowl Player’s Wives Fashion Extravaganza when she was honored as “Women Who Make Miracles Happen, Miracles in Medicine”, Volunteer Jacksonville Celebration of Service Award “Heart of Gold Award”, Accreditation Council for Graduate Medical Education Parker J. Palmer “Courage to Teach” Award, “Top Doctors in America”, The Jacksonville Business Journal “Super Educator Heroes in Medicine Award”, and The Florida Times Union “Eve Award” in the area of education. She also received the 2008 Recognition Award of the Iranian American Association. Dr. Masood will be inaugurated in Paris, France during the second week of June as the next President of “The World Society of Breast Health”. She is the mother of two accompanied physicians, Dr. Ali Kasraeian, a urologist and Dr. Sina Kasraeian, an orthopedic surgeon in training.
    

 
 
Adam Michael Clark, Ph.D.
Director of Health Policy
Lance Armstrong Foundation
Biography
Adam Clark, Ph.D.  is the Director of Health Policy at the Lance Armstrong Foundation. Dr. Clark has a background in biomedical science as a researcher, administrator, and health science advisor. Prior to coming to the Lance Armstrong Foundation, Dr. Clark served as a program officer and technology development specialist in the Office of Technology and Industrial Relations at the National Cancer Institute. In this role, Dr. Clark was the senior program developer of the Clinical Proteomic Technologies Initiative for Cancer, a five-year program intended to develop advanced technologies to detect low-level, cancer-related proteins circulating in blood in order to improve diagnosis, treatment, and therapeutic monitoring of cancer. These programs strove to integrate personalized medicine and early detection strategies in genomics, bioinformatics, and proteomics. 
Dr. Clark earned his doctorate in Environmental Health from the University of Cincinnati, College of Medicine in conjunction with the National Institutes of Health’s Graduate Partnership Program conducting research on signaling pathways and gene-environment interactions in tumor development.  
After moving from the research bench, Dr. Clark was accepted into the Department of Health and Human Services’ Emerging Leaders Program where he served as a science advisor and analyst in the Office of the Secretary of the Department of Health and Human Services and the White House’s Office of Science and Technology Policy. In these roles he was responsible for a number of life science issues including biomedical technologies, environmental health, nutrition, and overweight/obesity.  In 2005, after completing his work with the Emerging Leaders Program, Dr. Clark returned to the NCI Office of Technology and Industrial Relations. 
In 2007, Dr. Clark moved to the Lance Armstrong Foundation as the Director of Health Policy. In this capacity Dr. Clark oversees the policy positions and agendas of the Foundation. By incorporating his experiences in interdisciplinary biomedical research strategies he intends to improve local and national health policies in cancer diagnosis, treatment, and survivorship.
   


David Winialski

David was born in Connecticut – (which may help explain why he talks so fast!). His family relocated to Florida in the early 60’s and he grew up in Ft. Lauderdale. 
 
He attended the University of Florida, and is an avid Gator fan. In his early academic career he was a mechanical engineering student and had the opportunity to work as an engineering trainee at the Kennedy Space Center from 1981 -82. Duties there centered on the Space Shuttle program, and he designed tools that are still used in the assembly of the launch vehicle. 
 
Ultimately switching majors, he received his Bachelor’s of Science in Physiological Psychology. He undertook graduate studies in the UF College of Medicine, from which he received a Master’s Degree in Neuroscience (1989) with thesis work in neurosurgical repair of spinal cord injury, and has peer-reviewed published articles for this work. While he was pursuing a Ph.D. in the College’s Anatomy & Cell Biology program, he was offered an internship with the Florida House of Representatives. That internship resulted in a job offer to work as a committee staff analyst, and he has been in the legislative process ever since.
 
The bulk of his legislative career has been with the Florida Senate, where he served as Chief Legislative Assistant for Senators Don Sullivan, M.D. (from 1992-97) and Jim Sebesta (from 1998-2006). From 1997-98 he worked as a registered lobbyist. He currently serves as the Legislative Planning Director for the Department of Health.
 
He spends his limited leisure time pursuing a multitude of hobbies, including restoring a classic ‘65 Mustang, photography, Bonsai gardening, SCUBA diving, scale model building and cycling.



Carol Licko's practice focuses primarily on complex commercial litigation at all levels from trials through appeals, health and educational law, general business and corporate law, and constitutional law.

Carol served as General Counsel to Governor Jeb Bush from January 1999 through June 2000. As Governor Bush's first General Counsel, she acquired considerable experience in state governmental affairs, including statewide health care and educational reform, governmental/legislative relations, complex litigation management, media relations, and administration. Carol served two terms on the State Ethics Commission, and also served on the Governor’s Blue Ribbon Task Force established to improve state foster care and health services provided to dependent children. She currently serves as an officer of Our Kids, Inc., an organization charged with providing community-based foster care, health care, and educational services to such children.

Carol serves as counsel to The Scripps Research Institute in establishing Scripps Florida, a new state-of-the-art scientific research institute, in Palm Beach, Florida. She also represents the Torrey Pines Institute for Molecular Studies and the University of Miami Human Genomics Center in their successful applications for grant awards from Florida’s Innovation Incentive Fund. She continues to play a key role in efforts to develop Florida’s biotech cluster.
 
Carol has also successfully represented many large and small health care providers, including both profit and nonprofit hospitals, a major university medical school, a hospital district, a community college and its medical education campus, and private physician groups. She represents these health care providers in a wide variety of matters, from class action lawsuits to licensing matters, from issues involving the costs of malpractice cases to business torts and fraud, from discrimination cases to employment and other personnel issues, and from constitutional to general policy matters. She has appeared in state and federal trial courts throughout Florida and has argued appeals in the Florida Supreme Court, the Eleventh Circuit, and various Florida District Courts of Appeals. She has served for several years as General Counsel to WPBT-2, the largest PBS television station in Florida and the producer of the Nightly Business Report. Carol serves as General Counsel to the Miami-Dade College Foundation, serving the largest community college in the United States with more than 100,000 students.

Prior to becoming a member of the Florida Bar, Carol was a teacher and administrator for the Miami-Dade County Public School System, where she was named Dade County's Teacher of the Year and runner-up for the state of Florida's Teacher of the Year. Carol also acquired five years of part-time experience working at St. Francis Hospital in Miami Beach in a variety of health care and administrative roles.

At the University of Miami School of Law, Carol was an associate editor of the Miami Law Review.
   
Representative Experience
Representation of one of the largest nonprofit hospital systems in Florida in putative class action and other litigation involving hospital charges to insured and uninsured patients.

Representation of one of the world's largest scientific research institutes in its establishment of a new, state-of-the-art, scientific research institute in Palm Beach County, Florida.

Representation of one of the largest community colleges in the United States, including its medical education campus.

Representation of a major university and its medical school in efforts to reduce costs of medical malpractice cases.

Representation of a major hospital in licensing matters and related litigation.

 

Dr. Hurt has been involved in medical education and research for almost thirty years, first at the University of Tennessee, later at Baylor College of Medicine, and at Florida State University. She was the final director of the FSU Program in Medical Sciences and was very involved in the creation of the new College of Medicine in 2000, served as acting dean from 2000 to 2001, and was the founding faculty member of the College.  She currently serves as associate dean for research and graduate programs. She is now engaged in the development of a clinical research network for the College, with the potential to involve over 1300 part-time clinical faculty on six regional clinical campuses across Florida.  She is a professor in the College of Medicine's Department of Biomedical Sciences and leads a molecular biology research group engaged in dissecting the regulation of cellular division at the molecular level. She enjoys working with students in the laboratory and has directed the research of 12 doctoral students, one who earned an M.S., and 24 undergraduate researchers at FSU.   She was appointed by the Governor of the State of Florida in 2006 to the state's Biomedical Research Advisory Council.

   


 
A native of Valdosta, Georgia, Jack Sullivan, Jr. attended Davidson College, in Davidson, NC, attaining a BA in Psychology. He went on to further his studies at Vanderbilt University, were he graduated with an MBA, with a concentration in Finance. 

Today, he serves at the President and CEO of the Florida Research Consortium, a strategic partnership between Florida’s universities and the state’s business community. The consortium focuses on enhancing progressive research programs at Florida’s universities to expand Florida’s high-tech intellectual capital and promote quality economic growth. He was selected by the board to be its first President and CEO in November of 2002. Jack came to the FRC after 18 years as a business owner, where after a successful sale he became Vice-president of Acquisitions and Planning for the acquiring company. He played a major role with the company’s growth as it expanded five fold in four years to reach sales in excess of $810 million.
 
In his current position, Jack envisions the consortium as the link for research, providing balance between universities, the business community and Florida state government as we collectively seek to bring Florida’s technology economy into the top five in the nation. 
 
In addition to his business resume Jack has a significant volunteer leadership experience to draw upon. He has served on the Board and Executive Committee of the Georgia Chamber of Commerce as Vice-Chairman for economic development. He is a graduate, former program chair, Board of Trustee’s member and Chairman of the selection committee for Leadership Georgia. He was recognized for his role in the only successful removal of an Air Combat Command Facility from the 1991 BRAC process by Secretary of Defense William Perry who invited Jack to participate in the DOD’s Joint Civilian Orientation Conference program.
 
Jack is currently serves on the Boards of BioFlorida and Florida Lambda Rail, and is a member of the Florida Chamber of Commerce, Golden Eagle Country Club, and the Governor’s Club in Tallahassee and remains active as a commercial real estate investor.
 
He is married to the former Beth Hitchcock of Valdosta. Together they have four sons.

 


Todd E. Golde MD PhD

Narrative Biography
 
Dr. Golde is a Professor and Chair of the Neuroscience Department at Mayo Clinic. The Department of Neuroscience at Mayo Clinic is a group of scientists internationally renowned for its Alzheimer’s disease (AD) and Parkinson disease (PD) research. Dr. Golde received both his Ph.D. and M.D. degrees from Case Western Reserve University and completed his residency in the Department of Pathology and Laboratory Medicine at University of Pennsylvania Hospital, where he served as Chief Resident.
Dr. Golde has made significant contributions to the AD field. A few of these contributions are described here.  During his studies as an MD PhD student and postdoctoral fellow in the laboratory of Dr. Steven Younkin, he participated in pioneering studies showing that the amyloid beta protein was a normal metabolite and that genetic alterations that cause familial forms of AD altered production of the amyloid beta (Ab) protein These studies provided the primary support for the Ab hypothesis of Alzheimer’s disease, and also enabled drug discovery programs aimed at altering Ab production and deposition.
 Following completion of his residency training at the University of Pennsylvania, Dr. Golde began his independent research career in 1997 by trying to understand how different species of amyloid beta peptides were produced. These studies led to the identification of compounds that selectively lowered the production of the more toxic 42 amino acid long form the amyloid beta protein. One of the compounds identified, R-Flurbiprofen (FlurizanTM, tarenflurbil), was already in human trials for prostrate cancer, and thought to be very safe. Demonstration that R-Flurbiprofen lowered the “long” toxic form of the amyloid beta protein proved the rationale for clinical testing of R-Flurbiprofen as an AD therapeutic. Phase II studies of this compound have demonstrated the potential of this compound as a potential disease modifying AD therapeutic. Phase III studies are underway and will be completed in 2008.
Dr. Golde has published over 90 peer reviewed studies mostly on AD, and also contributed multiple book chapters and reviews. Dr. Golde was one of 46 investigators invited to speak at the recent 100th year commemoration of the first diagnosis of Alzheimer’s disease held in Dr. Alzheimer’s home town of Tubingen, German. Speakers were selected by their peers (a large group of distinguished AD researchers) in a transparent voting process. Dr. Golde has also received several grant based awards for his research. He was selected as a Beeson Scholar, an Ellison Medical Foundation Young Investigator, and more recently received the Zenith Award from the Alzheimer’s Association. He has received multiple grants from the NIH, and continues to maintain strong extramural support. Dr. Golde is a co-inventor on 2 issued patents, and is a co-inventor on 4 pending/provisional patents.
  

  
Dr. Morris practices Hematology, Internal Medicine and Oncology in Naples, Florida. Dr. Daniel Morris graduated from the University of Pittsburgh and currently serves as a council member to the King-Bankhead Coley Biomedical Research Program.
 

 

 

 

Email this

Registration & Logistics:
Andy Campbell
tel: (352) 392-1701 x246
fax: (352) 392-5437
Meeting Content:
Chuck Wells
tel: (850) 245-4444 x3933
fax: (850) 245-4371